Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma-Reference-Cited by-同舟云学术

Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma

Published:2021-06-16 Issue: Volume:Publish Ahead of Print Page:
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Allen Casey J.,Pointer David T.,Blumenthaler Alisa N.,Mehta Rutika J.,Hoffe Sarah E.,Minsky Bruce D.,Smith Grace L.,Blum Mariela,Mansfield Paul F.,Ikoma Naruhiko,Das Prajnan,Ajani Jaffer,Dineen Sean P.,Fleming Jason B.,Badgwell Brian D.,Pimiento Jose M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference28 articles.

1. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

2. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou;J Clin Oncol,2011

3. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction;Macdonald;N Engl J Med,2001

4. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine;Sakuramoto;N Engl J Med,2007

5. Multimodality therapy of localized gastric adenocarcinoma;Badgwell;J Natl Compr Canc Netw,2016

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative Chemoradiotherapy for Resectable Gastric Cancer;New England Journal of Medicine;2024-09-13

2. Association Between Radiotherapy and Non-Gastric Second Primary Malignancies in Patients with Resectable Gastric Cancer : A propensity-adjusted, population-based SEER analysis;2024-08-27

3. Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy;Annals of Surgical Oncology;2024-07-24

4. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma;Cancer Biomarkers;2024-04-15

5. Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma;Frontiers in Oncology;2024-04-12